Somatic hypermutation and switch recombination of immunoglobulin genes require the activity of the activation-induced deaminase, AID. Recent studies of mice deficient for the uracil-DNA glycosylase UNG, which removes U from DNA, suggest that AID catalyses the deamination of dC to dU during antibody diversification.
Somatic Hypermutation
Rada et al. [5] determined that both SHM and CSR were affected in mice deficient for the uracil-DNA glycosylase UNG. This enzyme removes the uracil base in a DNA duplex, creating an abasic (AP) site ( Figure  1 ). Although the frequency of somatic hypermutation of Ig genes was similar in UNG -/-and UNG +/+ mice, the mutation pattern was altered in the way predicted if dU were not removed following deamination of dC. As in UNG +/+ mice, approximately half of the mutations were targeted to C or G and half to A or T, but the resulting mutations arising from C or G were greatly skewed toward transitions -C to T and G to A. The transition:transversion ratios at C/G were 65:35 in UNG +/+ mice and 94:6 in UNG -/-mice.
This skewed mutation pattern suggests that AID is a dC deaminase (Figure 1 ), a proposal previously made following studies of SHM in a chicken B-cell line in which UNG had been inhibited [6] . Based on these and a plethora of other findings a current model of the process of SHM is summarized in Figure 1 . AID is likely to be the postulated mutator factor which (presumably together with a yet undefined co-factor) associates with a transcription complex at the promoter of an expressed Ig gene, travels with the RNA polymerase during transcript elongation, and is deposited on the DNA, perhaps when the RNA polymerase pauses [7] . AID deaminates a dC to dU, possibly with preference for the DNA sequence WRCY (W = A or T, R = purine, Y = pyrimidine), as this motif or its inverse, RGYW, is a hotspot for SHM that is retained in UNG -/-mice.
The U/G mismatch created by AID would be resolved in various ways, influenced by whether or not the U is removed by a uracil DNA glycosylase ( Figure  1 ). The recent findings suggest that the major dU glycosylase involved in SHM in mouse and chicken is UNG [5, 6] . The AP site resulting from UNG action would have various outcomes depending on a race between DNA replication and base excision repair (BER) [8] . If a replication fork arrives at the abasic site, the high-fidelity replicating polymerases, Pol δ δ or Pol ε ε, would be stalled and replaced by an error-prone bypass DNA polymerase, such as η η, ι ι, or ζ ζ, which have been implicated in SHM ([9,10] and C. Reynaud, personal communication). An error-prone DNA polymerase would place any dNTP (N) opposite the AP site (pathway 1 in Figure 1 ), creating a mismatched N/AP site that cannot be extended directly by a replicating polymerase. The error-prone Pol ζ ζ is efficient in extending the DNA chain from a mismatch, with the potential of also copying neighboring dNTPs with errors (pathway 2 in Figure 1 ) [11] . This could create mutations at any nucleotide near the site at which AID deaminated a dC. Eventually, when Pol ζ ζ has incorporated a correct nucleotide, normal replication by Pol δ δ or ε ε will resume. In general, AP sites can also be eliminated by nucleotide excision repair; however, this form of repair was found not to be essential for SHM [12] .
If BER wins the race with replication, a nick (not shown) or a gap (pathways 3 and 4 in Figure 1 ) would result in repair synthesis [8] . Normally in BER a gap is filled by Pol β β with an error rate of only about 1 in 2,000 dNTPs. Thus, in most cases no mutations would arise (pathway 3, namely when the gap is filled by C, in Figure 1 
Remaining Questions
While it needs to be proven biochemically, the DNA deamination model solicits an array of interesting questions and testable hypotheses. Among the most important is the question of how AID is targeted to variable and switch regions. Deamination of the wrong DNA sequences would be highly mutagenic. Transcription is likely to be an important part of the targeting mechanism but AID activity must be directed specifically, as not all transcriptionally active genes undergo SHM in activated B cells. Presumably, specific cis elements that target AID are present in the Ig enhancers (Figure 1) . In addition, AID may bind to Cγ1
